Ilana Fishman

Ilana Fishman has extensive work experience in the clinical trials and regulatory affairs field. Their most recent position is as the VP of Clinical, Regulatory, and QA Affairs at Exero Medical, starting in October 2021. Prior to that, they worked at Pluristem Therapeutics as the Director of Clinical Operations from June 2020 to August 2021. In this role, they were responsible for the successful execution of clinical trials, strategic planning, and management of the Clinical Operations department.

Ilana also served as a Project Manager at Immunicom, Inc. from February 2019 to May 2020, where they supported a First in Human Immunopheresis therapy study. Before that, they were the CEO and Founder of Endpoint CRO from March 2005 to May 2020, offering a full range of CRO services and providing clinical studies strategy consulting.

Ilana has also worked as a Clinical Studies Project Manager at Ark Surgical Ltd., a Clinical Study Manager at Immunity Pharma Ltd. (IPL), and as a CRO & Project Management Consultant at KAMADA. Additionally, they held positions as a CRO and Clinical Advisor at CoreAlert (#Trendlines Group), and in Clinical Monitoring & CRO Services at Bayer. Their earlier experience includes working as a Clinical Studies Consultant at Novartis, where they managed clinical trials in Oncology and handled genetic submissions.

Overall, Ilana Fishman has a strong background in clinical operations, project management, and regulatory affairs, with extensive experience in the biotech industry.

Ilana Fishman has a diverse education history spanning several years and fields of study. In 1988, they obtained a Bachelor of Science (BSc) degree in Mechanical Engineering from the Moscow Institute of Physics and Technology (State University) (MIPT). Ilana then went on to pursue a Master of Science (MSc) degree in Chemical Engineering from the same institution, completing it in 1990.

In 2012, Ilana Fishman participated in the Merage program as a fellow at the University of California, Irvine - The Paul Merage School of Business, focusing on the field of Business.

In 2018, they engaged in executive education at Reichman University, although the specific field of study is not mentioned.

The following year, in 2019, Ilana Fishman obtained an Audit Certification from Cambridge Innovation Institute// Barnett International. Ilana also received a Certified Auditor qualification for Medical Device and Pharmaceutical Products from the same institution.

Most recently, from 2021 to 2022, Ilana Fishman pursued an Executive Master of Business Administration (MBA) with a focus on Healthcare Innovation at Reichman University.

It is important to note that the exact timing of the obtained Certified Auditor qualification is not provided.